Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07700706

Silicate β-TCP vs Extended Sticky Bone for Peri-Implant Jumping Gap in Guided Immediate Implants: RCT

This randomized clinical trial compares three peri-implant jumping gap management approaches following fully guided immediate implant placement in the maxillary esthetic zone. Clinical and digital outcomes will be evaluated after immediate provisionalization and final restoration.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry Mansoura University

Al Mansurah, Dakahlia Governorate, Egypt

About this study

Seventy two patients will be randomly assigned to receive no graft, silicate-added β-TCP putty, or extended sticky bone for jumping gap management around immediately placed implants. A CAD/CAM provisional crown will be delivered immediately, and the final prosthesis will be placed after 3 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with non-restorable teeth in maxillary esthetic zone requiring dental extraction.
  • Age range: from18 to 50 years.
  • Adequate inter-arch relation and inter-occlusal space to accommodate the prosthetic restoration.
  • Jumping gap more than 2mm.
  • Patients with good oral hygiene.
  • Patients willing to participate in the study's follow-up intervals.

Exclusion criteria

  • Patients with any pathological lesion or aggressive periodontal disease at the planned surgical site impaired the immediate implant placement.
  • Alcohol or drug abuse.
  • Smokers.
  • Patients with systemic diseases that absolutely contraindicate implant placement (bleeding disorders, immunosuppression,…etc.)
  • Pregnancy.
  • Patients with para-functional habits (bruxism and clenching).
  • Lack of motivation or inability to maintain good oral hygiene.

Treatment and study plan

No grafting

Procedure

The peri-implant jumping gap was managed without grafting.

Silicate-Added β-TCP Putty

Procedure

The peri-implant jumping gap was managed using silicate-added β-TCP putty.

Extended Sticky Bone

Procedure

The peri-implant jumping gap was managed using extended sticky bone.

Primary outcomes

  1. Implant Stability

    Time frame: Immediate post-operative, 3 months, and 6 months.

    Implant stability will be evaluated using Osstell device based on resonance frequency analysis (ISQ values).

  2. Hard Tissue (Peri-implant bone)

    Time frame: - Immediately after implant placement - 6 months after implant placement.

    Marginal bone loss will be assessed using CBCT measured in mm.

Secondary outcomes

  1. Soft Tissue

    Time frame: Baseline, 1 month, 3 months, and 6 months.

    Soft tissue contour and peri-implant tissue condition will be assessed using digital intraoral scanning (STL files) using superimposition and modified sulcus bleeding index (mSBI).

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Clinical and Digital Outcomes of Silicate-Added β-TCP Putty and Extended Sticky Bone for Peri-Implant Jumping Gap Management Following Fully Guided Immediate Implant Placement in the Maxillary Esthetic Zone: A Randomized Clinical Trial

Acronym: JUMP-ESTHETIC

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 14, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.